Will India become the global centre for pharmaceutical research & development?

Journal of Generic Medicines

Volumn 3, Issue 3, 2006, Pages 194-200

  Singh, Malvinder Mohan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; GENERIC DRUG;

AGING; ARTICLE; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; COMPETITION; DRUG APPROVAL; DRUG COST; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; FORECASTING; GOVERNMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; LICENCE; MALTA; MERGERS AND ACQUISITIONS; PATENT; PATIENT CARE; PRESCRIPTION; PRODUCTIVITY;

EID: 33751556467     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4940119     Document Type: Article

References (5)

1. Recombinant Capital, 2003-2004 published in 'Progressions 2005', Ernst & Young Annual Global Pharmaceutical Report.
2. Deutsche Bank & SSB Research (2002).
3. OECD Health Data (2003), 3rd edn.
4. Pfizer (2003) IPHMR Conference, New Delhi, August.
5. Anon (2004), The Economic Times, February.